- Income Tax Expense (Benefit)
- Effective Income Tax Rate (EITR)
- Components of Deferred Tax Assets and Liabilities
- Adjustments to Financial Statements: Removal of Deferred Taxes
- Adjusted Financial Ratios: Removal of Deferred Taxes (Summary)
- Adjusted Net Profit Margin
- Adjusted Financial Leverage
- Adjusted Return on Equity (ROE)
- Adjusted Return on Assets (ROA)
Paying user area
Try for free
Cytokinetics Inc. pages available for free this week:
- Balance Sheet: Assets
- Balance Sheet: Liabilities and Stockholders’ Equity
- Common Stock Valuation Ratios
- Enterprise Value to EBITDA (EV/EBITDA)
- Present Value of Free Cash Flow to Equity (FCFE)
- Selected Financial Data since 2005
- Operating Profit Margin since 2005
- Current Ratio since 2005
- Debt to Equity since 2005
- Price to Book Value (P/BV) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Cytokinetics Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Income Tax Expense (Benefit)
12 months ended: | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Current income tax provision | |||||||||||
Deferred income tax provision | |||||||||||
Income tax provision |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
The financial data for the annual current and deferred income tax expenses reveals a consistent absence of recorded tax provisions from 2018 through 2022. Specifically, the categories for current income tax provision, deferred income tax provision, and total income tax provision all show no reported values across the entire period analyzed.
This lack of data could indicate that the company did not incur any income tax liabilities during these years, possibly due to operating losses, tax credits, or other tax attributes that offset taxable income. It might also reflect the company's tax strategy or status, such as being in a development phase with limited or no taxable profits.
The trend of zero or unreported income tax expenses over multiple years suggests a consistent tax position, potentially highlighting an absence of taxable income or deferred tax assets and liabilities recognized in the financial statements. Without recorded tax provisions, it is not possible to assess variability or impact of income taxes on the company's financial performance during this timeframe.
Overall, the data indicates stability in the income tax expense line items by way of non-recognition or zero values, pointing to potentially ongoing tax loss carryforwards or other tax considerations limiting the company's taxable income and resulting tax expense.
Effective Income Tax Rate (EITR)
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
The analysis of the tax-related percentages over the five-year period reveals several notable trends. The federal statutory tax rate remained constant at 21% throughout the period, indicating no legislative changes affecting this base rate. State tax, net of federal benefits, appeared intermittently, with minor variations ranging from 1% to 3%, suggesting fluctuations in state tax impacts or adjustments over time.
There is significant variability in the "Change in state effected rates," which oscillated between negative and positive values, peaking at 4% in 2019 and dropping to -4% in 2018. This pattern indicates adjustments in state tax calculations or tax law changes affecting the state tax burden at various points.
Tax credits, net, maintained a generally upward trend, increasing from 1% in 2018 to 4% by 2022. This progression suggests an improving position in terms of credits, possibly through increased qualified investments or regulatory incentives.
The "Change in valuation allowance" consistently recorded negative values each year, with a peak decrease of -30% in 2019, followed by gradual reductions but staying deep in the negative range through 2022. This repeated sizeable negative allowance change may reflect ongoing reassessments of deferred tax assets, potentially indicating management’s expectations of limited realizability of certain tax benefits.
Stock-based compensation as a percentage of tax-related items experienced minor fluctuations, initially negative in 2018 and 2019, then shifting to positive values of 1% or 2% from 2020 onward. This transition might suggest a shift in the impact or accounting treatment of stock-based compensation on tax expense components.
Other tax-related factors, though less defined, showed a slight negative trend beginning in 2020 and increasing to -2% by 2022, possibly attributable to various miscellaneous tax adjustments or costs.
Overall, while the federal statutory tax rate remained stable, there were dynamic changes in state tax effects, valuation allowances, tax credits, and compensation-related tax impacts, indicating active management of tax positions and fluctuating external tax environments over the analyzed period.
- Federal Statutory Tax Rate
- Remained constant at 21% from 2018 through 2022.
- State Tax, Net of Federal Benefits
- Variable with small values appearing intermittently; highest at 3% in 2019.
- Change in State Effected Rates
- Fluctuated between -4% and 4%, suggesting adjustments or changes in state tax calculations.
- Tax Credits, Net
- Displayed an increasing trend from 1% to 4%, indicating enhanced utilization or accrual of tax credits.
- Change in Valuation Allowance
- Consistently negative, with notable deep decline in 2019 (-30%), implying cautious outlook on deferred tax asset realizability.
- Stock-Based Compensation
- Shifted from negative to positive percentages between 2018 and 2020, reflecting changes in tax treatment or the magnitude of stock-based compensation.
- Other
- Minor negative impact beginning in 2020, reaching -2% by 2022, likely due to miscellaneous tax-related factors.
Components of Deferred Tax Assets and Liabilities
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
The financial data reveals several notable trends and changes over the analyzed periods.
- Net Operating Loss Carryforwards
- There is a consistent upward trend in net operating loss carryforwards, increasing steadily from 121,748 thousand US dollars in 2018 to 202,459 thousand US dollars by the end of 2022. This indicates ongoing accumulated losses that can potentially reduce future taxable income.
- Tax Credits
- Tax credits have also increased steadily, from 64,797 thousand US dollars in 2018 to 98,292 thousand US dollars in 2022, demonstrating growth in credits available, likely supporting future tax reductions.
- Liability Related to Sale of Future Royalties
- This liability shows a significant increase, particularly noticeable in 2022 where it nearly doubled from the previous year's value, rising to 68,366 thousand US dollars. This increase suggests heightened obligations related to previously arranged royalty sales.
- Reserves and Accruals
- These have more than quadrupled over the span, growing from 5,772 thousand US dollars in 2018 to 23,950 thousand US dollars by 2022, reflecting either increased anticipated expenses or liabilities.
- Capitalized Research and Development (R&D)
- Capitalized R&D values declined sharply from 4,614 thousand US dollars in 2018 to 1,115 thousand US dollars in 2021, before jumping substantially to 48,047 thousand US dollars in 2022. This notable spike in the final year suggests a significant shift in capitalization of development costs.
- Long-term Lease Liability
- The long-term lease liability, recorded from 2019 onward, shows a sharp increase from 718 thousand US dollars in 2020 to 28,901 thousand US dollars in 2022, indicating a substantial increase in lease-related financial commitments.
- Deferred Revenue
- Deferred revenue appears only in 2021 at 18,608 thousand US dollars, with no subsequent data for 2022, suggesting recognition or reclassification changes in revenue timing for that period.
- Depreciation and Amortization
- This category shows a fluctuating pattern with initial increases until 2020, followed by notable negative values in 2021 and 2022 (-7,664 and -7,909 thousand US dollars, respectively), which may indicate reversal entries or accounting adjustments in those years.
- Noncurrent Deferred Tax Assets and Valuation Allowance
- Noncurrent deferred tax assets have increased consistently from 223,811 thousand US dollars in 2018 to 470,015 thousand US dollars in 2022. Offsetting this, the valuation allowance has also risen in magnitude, from -221,109 thousand to -443,914 thousand US dollars, reflecting cautious recognition of these assets. The resulting net amount (noncurrent deferred tax assets less valuation allowance) fluctuated, peaking in 2021 at 31,603 thousand US dollars but slightly dropping to 26,101 thousand US dollars in 2022.
- Accounting Method Change
- Negative values are reported for accounting method changes in 2018 to 2020, showing a decreasing magnitude from -2,682 to -927 thousand US dollars, with no associated values afterward, possibly reflecting the cessation or completion of certain accounting adjustments.
- Operating Lease Right-of-Use Assets
- From 2019 to 2022, these assets exhibit declining values from -1,484 to -18,192 thousand US dollars, indicating either amortization of these assets or impacts from lease modifications.
- Convertible Notes
- Convertible notes decreased in absolute value from -12,011 thousand US dollars in 2019 to -8,296 thousand US dollars in 2021, showing a gradual reduction in this form of debt or obligation.
- Other Items
- Instances of miscellaneous other items are small and sporadic, including minor positive and negative amounts without clear trends.
Adjustments to Financial Statements: Removal of Deferred Taxes
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
The analyzed data reveals significant fluctuations in reported and adjusted stockholders’ equity as well as net loss values over the five-year period from 2018 to 2022.
- Stockholders’ Equity (Reported and Adjusted)
- Both reported and adjusted figures are identical, indicating no adjustments separate from reported amounts within the data period. The values show considerable volatility:
- In 2018, stockholders’ equity was positive at approximately $25.9 million. However, in 2019, it declined sharply to a negative $10.9 million, indicating a deficit.
- Subsequently, a strong recovery occurred in 2020 and 2021, with equity increasing to $113.4 million and then further to $243.9 million, representing substantial positive growth.
- In 2022, equity dropped precipitously to a negative $107.9 million, marking a significant deterioration and return to deficit territory.
- Net Loss (Reported and Adjusted)
- Similar to equity, reported and adjusted net loss figures are identical, showing no adjustments.
- Net losses increased consistently and substantially each year, beginning with a loss of approximately $106.3 million in 2018 and worsening annually:
- The loss grew to $121.7 million in 2019, then $127.3 million in 2020.
- A pronounced increase occurred in 2021, with net loss rising sharply to $215.3 million, followed by an even greater loss of $389.0 million in 2022.
- This trend suggests continuously intensifying operational challenges or increased expenditures leading to significantly higher losses over time.
Overall, the analysis exhibits a pattern of increasing financial distress, with equity fluctuating sharply and ending in deficit, while losses escalate markedly year-over-year. The data indicates growing financial strain and volatility in the company's financial position during the examined period.
Cytokinetics Inc., Financial Data: Reported vs. Adjusted
Adjusted Financial Ratios: Removal of Deferred Taxes (Summary)
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
- Net Profit Margin
- The reported and adjusted net profit margins exhibit a consistently negative trend across the observed periods, indicating sustained net losses. Starting from -337.41% in 2018, the margin worsened to -452.93% in 2019, improved somewhat in 2020 to -228%, but then deteriorated again to -305.72% in 2021 and further to -411.21% in 2022. This fluctuation suggests ongoing challenges in achieving profitability with significant volatility over the years.
- Financial Leverage
- Financial leverage shows a general declining trend over the available periods. The ratio decreased from 8.14 in 2018 to 4.71 in 2020, and further to 3.45 in 2021. The data for 2019 and 2022 are missing. This reduction may indicate efforts to lower reliance on debt or other leveraged financing, which could impact risk exposure and capital structure.
- Return on Equity (ROE)
- ROE values, both reported and adjusted, are negative throughout the observed periods and demonstrate improvement over time. From a very high negative value of -409.84% in 2018, the ratio was not reported for 2019 but improved to -112.27% in 2020 and further to -88.29% in 2021. Data for 2022 is missing. Despite remaining negative, this upward trend suggests a reduction in losses relative to shareholder equity.
- Return on Assets (ROA)
- The reported and adjusted ROA indicates persistent losses with some improvement around 2020 and 2021, followed by a decline in 2022. Starting at -50.33% in 2018, the ROA improved to -41.99% in 2019, further to -23.85% in 2020, marginally worsened to -25.59% in 2021, and then declined again to -38.33% in 2022. This trend reflects continued inefficiencies in asset utilization to generate profit.
- Summary
- Overall, the financial indicators reflect ongoing operational and profitability challenges, with large negative margins and returns persistently observed. Although leverage ratios declined, suggesting possible deleveraging, profitability and asset returns remain negative. The improvements in ROE and ROA during certain periods imply transient reductions in losses, but the reversal in 2022’s ROA and net profit margin indicates persistent performance issues. Missing data for some periods limits a complete temporal analysis, but the available information illustrates a trajectory of substantial financial strain.
Cytokinetics Inc., Financial Ratios: Reported vs. Adjusted
Adjusted Net Profit Margin
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
2022 Calculations
1 Net profit margin = 100 × Net loss ÷ Revenues
= 100 × ÷ =
2 Adjusted net profit margin = 100 × Adjusted net loss ÷ Revenues
= 100 × ÷ =
- Reported and Adjusted Net Loss
- The net loss figures exhibit a consistent and significant increase over the five-year period from 2018 to 2022. The reported and adjusted net loss values are identical throughout, indicating no adjustments have altered these figures. Starting at approximately $106.3 million in 2018, the net loss increased progressively each year, reaching about $389.0 million in 2022. Notably, the largest incremental jump occurred between 2021 and 2022, where the net loss nearly doubled from $215.3 million to $389.0 million.
- Reported and Adjusted Net Profit Margin
- The reported and adjusted net profit margins, both expressed as negative percentages, follow a similar pattern to the net loss values, reaffirming that adjustments did not affect these ratios. The margin worsens sharply from -337.41% in 2018 to -452.93% in 2019. Thereafter, there is an improvement in 2020 to -228%, but this is short-lived as the margin steepens again to -305.72% in 2021, and then significantly deteriorates to -411.21% in 2022. This pattern suggests volatility in profitability relative to revenue or other underlying factors, with an overall trend indicating increased losses relative to whatever base the margin is calculated upon.
- Overall Trend and Insights
- The data reveals a persistent and growing net loss situation over the five years, with losses escalating both in absolute dollar terms and as a percentage in profit margin terms. The equivalence of reported and adjusted figures suggests limited impact of tax-related adjustments on the net loss and margin metrics during this period. The fluctuations in the net profit margin, particularly the partial recovery in 2020 followed by deterioration, may indicate episodic changes in operational efficiency, revenue generation, or cost structure that merit further detailed investigation. The dramatic increase in net loss in 2022 signals potential intensified challenges, such as elevated expenses or lower revenues, affecting financial performance significantly.
Adjusted Financial Leverage
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
2022 Calculations
1 Financial leverage = Total assets ÷ Stockholders’ equity (deficit)
= ÷ =
2 Adjusted financial leverage = Total assets ÷ Adjusted stockholders’ equity (deficit)
= ÷ =
The analysis of stockholders’ equity and financial leverage over the five-year period reveals notable fluctuations and distinct trends.
- Stockholders' Equity (Reported and Adjusted)
-
Both reported and adjusted stockholders’ equity exhibit identical values across the periods, indicating that adjustments for deferred income tax did not alter the overall equity figures. The equity started at a positive level of US$ 25.9 million in 2018 before declining sharply to a deficit of approximately US$ 10.9 million in 2019. This was followed by a significant recovery and substantial increase, reaching US$ 113.4 million in 2020 and further escalating to US$ 243.9 million in 2021. However, in 2022, the stockholders’ equity reverted to a significant deficit of approximately US$ 107.9 million.
This volatile pattern underscores considerable variability in the company’s net asset position, highlighting a period of recovery and growth between 2019 and 2021, succeeded by a notable decline in 2022 to a deficit level exceeding that seen in 2019.
- Financial Leverage (Reported and Adjusted)
-
The financial leverage ratio is reported and adjusted identically, with data available for 2018, 2020, and 2021. It begins at a high level of 8.14 in 2018, decreases significantly to 4.71 in 2020, and further declines to 3.45 in 2021. Data is missing for 2019 and 2022, preventing a complete year-over-year analysis across the entire period.
The downward trend in financial leverage from 2018 to 2021 suggests a gradual reduction in the company’s debt relative to equity, indicating improved capital structure or reduced reliance on borrowing during this interval. However, the absence of data for key years and the equity deficit experienced in 2022 complicate a full assessment of leverage dynamics for the most recent period.
Overall, the data reflects pronounced volatility in stockholders’ equity over the years with a peak in 2021, accompanied by a general trend toward reduced financial leverage in available data years. The reversal to a significant equity deficit in 2022 is a critical point warranting further investigation to understand underlying causes and implications for financial stability.
Adjusted Return on Equity (ROE)
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
2022 Calculations
1 ROE = 100 × Net loss ÷ Stockholders’ equity (deficit)
= 100 × ÷ =
2 Adjusted ROE = 100 × Adjusted net loss ÷ Adjusted stockholders’ equity (deficit)
= 100 × ÷ =
- Net Loss Trends
- The reported and adjusted net loss consistently increased throughout the five-year period. Starting at a loss of approximately $106.3 million in 2018, the net loss escalated annually, reaching nearly $389.0 million by the end of 2022. Notably, the most significant year-over-year increase occurred between 2021 and 2022, where the net loss almost doubled.
- Stockholders’ Equity (Deficit) Fluctuations
- Stockholders’ equity showed considerable volatility over the observed period. It began with a positive value of about $25.9 million in 2018, turned negative in 2019 reaching approximately -$10.9 million, and then recovered significantly in 2020 and 2021, peaking near $243.9 million. However, in 2022, stockholders’ equity dropped sharply to a deficit of roughly -$107.9 million, marking a substantial reversal from the prior positive trend.
- Return on Equity (ROE) Behavior
- Return on equity ratios, both reported and adjusted, were consistently negative when available, reflecting the sustained net losses. In 2018, ROE was deeply negative at -409.84%, with missing data for 2019. In subsequent years, ROE improved somewhat but remained negative (-112.27% in 2020 and -88.29% in 2021). The absence of data for 2022 ROE limits further analysis for the latest period.
- Insights
- The data indicates a persistent downward pressure on profitability, as evidenced by the widening net losses over the years. Although stockholders’ equity rebounded temporarily in 2020 and 2021, the reversal to a substantial deficit in 2022 suggests increased financial stress or other adverse events affecting the company’s capital structure. The negative and volatile ROE figures corroborate the challenges faced in generating shareholder value during this timeframe.
Adjusted Return on Assets (ROA)
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
2022 Calculations
1 ROA = 100 × Net loss ÷ Total assets
= 100 × ÷ =
2 Adjusted ROA = 100 × Adjusted net loss ÷ Total assets
= 100 × ÷ =
- Net Loss Trends
- The reported and adjusted net loss figures consistently increased in absolute value over the five-year period, indicating a worsening net loss situation for the company. Starting from a loss of approximately $106.3 million in 2018, the net loss deepened progressively each year reaching nearly $389.0 million in 2022. The most significant jump occurred between 2021 and 2022, where the net loss almost doubled, suggesting heightened operational or financial challenges during that final year.
- Return on Assets (ROA) Trends
- The reported and adjusted Return on Assets percentages mirrored each other exactly and displayed significant negative values throughout. The ROA improved somewhat from -50.33% in 2018 to -23.85% in 2020, indicating a relative gain in asset efficiency during this timeframe despite being negative. However, from 2020 onward, the ROA deteriorated again, moving to -25.59% in 2021 and worsening substantially to -38.33% in 2022. This pattern suggests initial improvements were not sustained, and asset utilization efficiency declined sharply in the latest period.
- Overall Financial Performance
- The data demonstrates a pattern of increasing losses coupled with volatile but largely negative asset efficiency. Despite a temporary improvement in ROA around 2020, both net losses and negative ROA deepen significantly by 2022, highlighting escalating financial strain. The identical figures for reported and adjusted metrics imply no adjustments related to income tax significantly altered the company's net loss or asset return profile during the reporting periods.